Filetype
WCMM Clinical Researcher | Pediatric Rheumatology Our research Can children get rheumatic joint disease? Is it a life-long disease? Does my child really need all these drugs?! These are the questions we hear every week when meeting families to children with newly diagnosed inflammatory joint disease. To get a chronic disease will have a major impact on your day-to-day life and suddenly you are dif
https://www.wcmm.lu.se/robin-kahn - 2026-01-01
WCMM Clinical Researcher | Translational Lung Transplantation & Cell Therapy Research Our research The Lindstedt group is led by Professor Sandra Lindstedt, a senior consultant in thoracic surgery specializing in heart and lung transplantation, with a long-standing interest in lung transplantation related research, post-transplant complications and lung regeneration. Lung transplantation (LTx) is
https://www.wcmm.lu.se/sandra-lindstedt - 2026-01-01
WCMM Clinical Researcher | Tumor Microenvironment Our research Despite recent advances, there is still a substantial unmet medical need for novel cancer therapeutics. A new class of pharmacological compounds, based on RNA, open up new possibilities to specifically target numerous cancer cell vulnerabilities. Cytosolic delivery of the macromolecular RNA molecules is the biggest hurdle to translate
https://www.wcmm.lu.se/anders-wittrup - 2026-01-01
The WCMM Friday club started in spring 2019 as a monthly scientific meeting for all clinical and preclinical PIs at WCMM Lund. It serves as a platform for presenting ongoing scientific work in each member’s research program. The informal format allows for open discussions, brainstorming and encourages new collaborations. WCMM Friday Club | November 2024 29th November | Host: Leigh Lab12:00-12:30
https://www.wcmm.lu.se/whats/wcmm-friday-club - 2026-01-01
DDLS Fellow | Systems Immunology My background Camila Consiglio is a DDLS fellow and group leader of the Systems Immunology Lab at Lund University. Camila is originally from Brazil, where she obtained her BS and MSc (Federal University of Rio Grande do Sul, in Porto Alegre, Brazil). She obtained her PhD in Immunology at Roswell Park Comprehensive Cancer Center (Buffalo, USA) and with a short stay
https://www.wcmm.lu.se/camila-consiglio - 2026-01-01
2023 | "AI in Regenerative Medicine"Organizing Committee | Inês Maria Nascimento Caiado, Denis Kovalenko and Camila Vazquez EchegarayHighlights from the programKeynote Speaker | Jacob Vogel, DDLS FellowTitle: Achieving biological insight and clinical utility from human neurodegenerative disease data through statistical learningWCMM Trainee Short TalksIlia Kurochkin (Pereira group): “A transcriptio
https://www.wcmm.lu.se/whats/wcmm-research-day/wcmm-research-day-2023 - 2026-01-01
Paul Bourgine Molecular Skeletal Biology Iben Lundgaard Glia-Immune Interactions Anja Meissner Vascular Biology Joao Duarte Diabetes & Brain Function Darcy Wagner Lung Bioengineering and Regeneration Nicholas Leigh Regenerative Immunology Filipe Pereira Cell Reprogramming in Hematopoiesis and Immunity Niklas Mattsson-Carlgren Clinical Memory Research Vinay Swaminathan Cell Mechanobiology
https://www.wcmm.lu.se/explore-our-research-groups/wcmm-fellows - 2026-01-01
The Knut and Alice Wallenberg Foundation supports long-term, free basic research beneficial to Sweden, mainly in medicine, technology, and the natural sciences. This is achieved through long-term grants to excellent researchers and to projects. The foundation also initiates grants to strategic projects and scholarship programs. WCMMThe Wallenberg Centers for Molecular Medicine represents an initia
https://www.wcmm.lu.se/wallenberg-center-molecular-medicine-lund/joint-nation-effort - 2026-01-01
DDLS Fellow | Clinical Memory Research Our research Research in the Dementia Multi-Omics and Neuroimaging (DeMON) lab focuses on aging and neurodegenerative disease, where we take advantage of large data resources to model disease progression and discover contributions to disease pathogenesis. Some of the lab’s principal research avenues include characterizing individual difference in disease prog
https://www.wcmm.lu.se/jacob-vogel - 2026-01-01
Basic scientists Alumni Clinical researchers Data-Driven Life Science (DDLS) Program
https://www.wcmm.lu.se/explore-our-research-groups - 2026-01-01
Camila Consiglio System Immunology Jacob Vogel Clinical Memory Research Qiaoli Wang Integrative Pancreatic Cancer Research What is DDLS? In 2020, KAW launched a new, national 12-year and 3.1 billion effort called SciLifeLab & Wallenberg National Program for Data-Driven Life Science (DDLS). The program is coordinated by SciLifeLab, which includes 11 universities and partner organizations, the four
https://www.wcmm.lu.se/explore-our-research-groups/ddls-fellows - 2026-01-01
Anders Wittrup Tumor Microenvironment Kees-Jan Pronk Hematopoietic & Immune Development Gesine Paul-Visse Translational Neurology Karin Tran Lundmark Vessel Wall Biology Andreas Edsfeldt Cardiovascular Research - Translational Studies Robin Kahn Musculoskeletal System Elin Trägårdh Nuclear Medical Imaging Lisa Påhlman Infection Medicine Martin Magnusson Cardiovascular Research Sandra Lindstedt Cli
https://www.wcmm.lu.se/explore-our-research-groups/clinical-researchers - 2026-01-01
"Tissue & Bioengineering in Molecular Medicine" Program 08:30 - 08:50 | Coffee & mingle 08:50 - 09:00 | Welcoming words | Prof. Gunilla Westergren-Thorsson, Director09:00 - 09:50 | Keynote Speaker | Prof. Maria Tenje, Uppsala University10:00 - 10:40 | LU Infrastructures10:40 - 12:00 | WCMM Trainees Short talks10:40 - 11:00 | Atul Kumar | Clinical Memory Research | Title: “Cell-specific polygenic r
https://www.wcmm.lu.se/whats/wcmm-research-day/wcmm-research-day-2024 - 2026-01-01
Martin Magnusson Wallenberg Molecular Medicine Clinical Researcher – Diabetes The core of our research is to bridge the surprisingly under-explored gap between the “omics” of epidemiology (e.g. genomics, metabolomics and proteomics) and biological and clinical function. Thus, a major component our research is to enhance the understanding of causes to progressing diabetes and cardiovascular disease
https://www.wcmm.lu.se/wcmm-lund-researchers/wcmm-clinical-researchers - 2026-01-01
Gunilla Westergren-Thorsson Director Email: gunilla [dot] westergren-thorsson [at] med [dot] lu [dot] se Telephone: +46 46 222 86 95 Mobile: +46 70 594 63 60 Kristian Pietras Co-director Email: kristian [dot] pietras [at] med [dot] lu [dot] se Telephone: +46 46 222 05 80 Lars Dahlin Clinical co-director Email: lars [dot] dahlin [at] med [dot] lu [dot] se Telephone: +46 40 33 17 24 Lisa Karlsson Sc
https://www.wcmm.lu.se/wallenberg-center-molecular-medicine-lund/management - 2026-01-01
What is WCMM Fusion 2025?This exhibition invites you to explore the fascinating intersection of science and art through stunning medical images created by the talented WCMM scientists. Each artwork tells a unique story of ongoing research, how it contributes to advancing scientific knowledge or addresses a specific medical need, and how far the research is with the goal of ultimately impacting cli
https://www.wcmm.lu.se/whats/wcmm-fusion-2025-where-science-meets-art - 2026-01-01
Postdoctoral program designed to foster cutting-edge translational research WCMM Lund is taking a significant step forward in training the new generation of young international, highly qualified postdoc candidates within the field of regenerative medicine with the launch of its IGNITE Postdoc Fellow Program. This initiative, funded by the Wallenberg Foundation, aims to support postdoctoral researc
https://www.wcmm.lu.se/ignite-postdoc-fellow-program - 2026-01-01
Cancer is a worldwide health challenge leading to increased mortality and diminishing quality of life of millions of people. In recent years, immunotherapy has transformed cancer treatment, but targeting effectively refractory solid tumours remains a challenge due to poor T cell activation. Downregulation of antigen presentation pathways and lack of professional antigen presenting cells in the tum
https://www.wcmm.lu.se/driving-tumor-antigen-presentation-rna-mediated-transdifferentiation - 2026-01-01
The emergence of induced pluripotent stem cells (iPS) has offered unprecedented opportunities in developmental biology and regenerative medicine. Generated from patient cells, iPS maintains their genetic features, allowing deciphering healthy or pathological processes in a personalized fashion. Applied to hematopoiesis, this technology holds enormous promises towards generating transplantable hema
https://www.wcmm.lu.se/human-ossicles-ips-hsc-development-and-leukemia-modeling - 2026-01-01
